In this 52-week trial of 1,698 people with type 2 diabetes whose blood sugar wasn't adequately controlled on Metformin, orforglipron outperformed oral semaglutide on every primary and secondary endpoint, including A1C reduction and weight loss, with improvements visible as early as four weeks
This research was supported by US National Institutes of Health grants R01 HL103866 (S.L.H.), P20 HL113452 (S.L.H
Italy 6.4.4.1
If something is sold as a research chemical, somehow its okay for anyone to buy it, which is crazy to me, he says
A current prescription or letter from the prescribing physician should include the patient's name, medication name (both brand and generic: tirzepatide/Mounjaro or tirzepatide/Zepbound), dosage, administration route, and confirmation of medical necessity
Both are GLP-1 medications approved for weight loss , so they work in similar ways